The incidence of opportunistic infections in patients with psoriatic arthritis treated with biologic and targeted synthetic agents: A systematic review and meta-analysis

Background: Biologic (bDMARD) and targeted synthetic (tsDMARD) disease-modifying anti-rheumatic drugs have broadened the treatment options and are increasingly used for patients with psoriatic arthritis (PsA). These agents block different pro-inflammatory cytokines or specific intracellular signalin...

Descripción completa

Detalles Bibliográficos
Autores principales: Vassilopoulos, Athanasios, Shehadeh, Fadi, Benitez, Gregorio, Kalligeros, Markos, Cunha, Joanne S., Cunha, Cheston B., Mylonakis, Eleftherios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579334/
https://www.ncbi.nlm.nih.gov/pubmed/36278224
http://dx.doi.org/10.3389/fphar.2022.992713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579334/
https://www.ncbi.nlm.nih.gov/pubmed/36278224
http://dx.doi.org/10.3389/fphar.2022.992713

Ejemplares similares